As a
general anesthetic widely used in surgical,
sevoflurane has been shown to cause cognitive and
memory deficits in the elderly. It's important to find out agents that can counteract
sevoflurane-induced
cognitive dysfunction. This study is aimed to investigate the effect of
lovastatin on
sevoflurane-induced
cognitive impairment in aged rats and reveal the potential mechanisms. BV-2 cells, rat hippocampal neurons or male aged rats were exposed to 2%
sevoflurane for 5 h. The cells were pretreated with 10 μM
lovastatin. The rats were intraperitoneally injected with 5 mg/kg/day
lovastatin for three days. The results showed that
lovastatin enhanced exosomal IDE secretion from
sevoflurane-exposed BV-2 cells and promoted Aβ degradation.
Lovastatin treatment also inhibited the increased expressions of β-
secretase 1 (BACE1) and γ-
secretase in hippocampal neurons under
sevoflurane exposure in vitro. In animal experiments, the discrimination index in novel object recognition test and percentage of spontaneous alternation in Y-maze test were significantly elevated after
lovastatin administration. In addition, Aβ plaque area and contents of soluble Aβ1-40 and Aβ1-42 in the hippocampal tissues were decreased upon
lovastatin treatment. Furthermore,
lovastatin reversed
sevoflurane-induced Aβ accumulation via up-regulating IDE expression, and down-regulating
amyloid precursor
protein (APP)-related
protein expression (β-C-terminal fragment (CTF), BACE1 and γ-
secretase). In conclusion,
lovastatin alleviates
sevoflurane-induced cognitive deficient in aged rats via promoting Aβ degradation and reducing Aβ production.
Lovastatin may be beneficial in preventing
anesthetic-induced
cognitive impairment.